Mangalam Drugs VS Pharmaceuticals & Biotechnology 
1D
0%
0%
1W
0.87%
0.69%
1M
6.35%
-3.28%
YTD
17.11%
-12.19%
1Y
-56.63%
-8.43%
3Y
-68.39%
13.36%
5Y
-77.99%
24.61%
10Y
-80.81%
161.01%
- Stock Absolute Returns
- India SENSEXAbsolute Returns
Price + DividendTotal Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.26%
0%
11.26%
6 Months
11.3%
0%
11.3%
1 Year
-56.63%
0%
-56.63%
2 Years
-74.56%
0%
-74.56%
3 Years
-68.39%
0%
-68.39%
4 Years
-78.88%
0%
-78.88%
5 Years
-77.99%
0%
-77.99%
Latest dividend: 0.5 per share ex-dividend date: Dec-21-2017
Return QuartilesWhat is a Quartile?
Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.
Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on
Return Quartiles - by Closest Peers
Inconsistent Performance
Mangalam Drugs and Organics Ltd has not been a consistent performer in the YTD and longer periods
1
Quartile
QTD
13.29%
4
Quartile
Mar-Jun
2.81%
1
Quartile
Dec-Mar
0.54%
4
Quartile
YTD
-56.63%
4
Quartile
2025
-76.09%
2
Quartile
2024
17.53%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry
Underperformer
Mangalam Drugs and Organics Ltd has been in the Third and Fourth Quartile in the YTD and longer periods
2
Quartile
QTD
13.29%
4
Quartile
Mar-Jun
2.81%
1
Quartile
Dec-Mar
0.54%
4
Quartile
YTD
-56.63%
4
Quartile
2025
-76.09%
3
Quartile
2024
17.53%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap
Not enough Stock Price history for Quartile Analysis
Risk Adjusted Returns v/s India SENSEXReturns BetaReturns Beta
Beta has not been calculated since enough price history is not available
Footer loading
